The Effect of Education Provided With Pecha Kucha Method on Cancer Patients Receiving Chemotherapy on Symptom Management and Quality of Life
Launched by ATATURK UNIVERSITY · Jan 26, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific teaching method, called Pecha Kucha, can help cancer patients who are undergoing chemotherapy manage their symptoms and improve their quality of life. The Pecha Kucha method uses a fast-paced presentation style with images and minimal text, allowing patients to learn important information quickly and effectively. The goal is to see if this way of providing education can help patients feel better and cope with the challenges of cancer treatment.
To participate in this trial, individuals must be 18 years or older, be at least in the second or third stage of cancer, and should be able to communicate verbally without any disabilities. Participants will receive information about managing their symptoms and improving their quality of life through the Pecha Kucha presentations. By joining this study, patients may gain valuable skills to help them during their treatment and share their experiences with others in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being 18 years or older,
- • Not having a verbal communication disability (hearing and speaking),
- • Being a Cancer Patient in the second or third stage
- Exclusion Criteria:
- • -
About Ataturk University
Atatürk University, located in Erzurum, Turkey, is a prominent academic institution dedicated to advancing research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative medical research aimed at improving patient outcomes and contributing to the global body of health knowledge. Committed to ethical standards and rigorous scientific methodologies, Atatürk University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of its clinical trials, ultimately enhancing the quality of care and driving advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Elazığ, Merkez, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials